Chapter 5
Victor insisted the executive samples were a mistake.
According to him, operations staff moved the wrong pallets before the quality hold was finalized.
That could happen.
Large warehouses made ugly mistakes.
Then emails contradicted him.
A warehouse supervisor wrote to Adrian:
M7-442B still blocked in ERP. Cannot transfer to professional sample inventory.
Adrian replied:
Use manual release. Victor approved.
Supervisor:
Quality signature required.
Adrian:
I am overriding for noncommercial use. These are not for retail sale.
Victor was copied.
He responded with a thumbs-up emoji.
The investigator reading the printout looked almost insulted by how ordinary it was.
A thumbs-up.
Thousands of prenatal bottles.
Then distribution expanded.
Some executive samples went to employees and family.
Some went to physician offices.
Some were included in promotional starter kits for maternal-health practices.
Costa Materna maintained that promotional samples were not “commercially distributed” in the same way as retail units.
Regulators disagreed with the implication.
Free product still reached consumers.
Pregnant consumers.
The FDA and state health departments began tracing lots.
They did not announce a nationwide catastrophe.
Only specific lots were implicated.
The company issued a voluntary recall of three prenatal batches and one related mineral product.
Clinicians were advised to identify patients with confirmed use and determine appropriate testing individually.
Then came the first confirmed outside case.
A woman in Connecticut had received a sample bottle from her obstetric office.
Her blood lead level was elevated.
Could Costa Materna prove the supplement caused it?
Not immediately.
She lived in an older home undergoing renovation.
Another plausible source existed.
Second case:
No elevated blood lead.
Third:
Borderline.
Fourth:
Elevated, but patient also used imported ceramic cookware.
Causation was messy.
That mattered legally.
Lucia’s case was stronger because investigators had her bottle, her timeline, her home environment testing, and internal batch records.
Home testing found no meaningful lead source.
Water was within regulatory limits.
No renovation.
No occupational exposure.
Her bottle remained the most plausible identified source.
Then Victor tried to narrow the dispute.
He offered through lawyers to pay for Lucia’s complete medical care, independent fetal monitoring, future pediatric testing, and a substantial settlement.
No admission of wrongdoing.
Lucia’s attorney asked:
“In exchange for what?”
“Confidential resolution of personal-injury claims.”
“And regulatory cooperation?”
“She remains free to comply with lawful process.”
“Voluntary interviews?”
Victor’s lawyer paused.
“Those would be addressed separately.”
Lucia refused.
Then Salvatore discovered why Victor needed the matter contained quickly.
Costa Materna was not merely facing a recall.
May you like
Its bank had scheduled a field examination.
And a very large borrowing-base certificate was due in nine days.
